Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and ...

SAN ANTONIO, July 07, 2026--bioAffinity Technology reports continued acceleration in commercial sales for its CyPath® Lung ...

A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can ...

Among patients with a very early diagnosis of systemic sclerosis (VEDOSS), a baseline diffusing capacity of the lungs for carbon monoxide by single breath (DLCO/SB) below 70% was associated with a ...

Removing a patient’s race from an equation used to assess lung function — a change called for by health equity advocates — would mean that the lung disease of nearly half a million Black Americans ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit ...

The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease ...

Getting Covid could increase your risk of developing pulmonary hypertension, a deadly blood pressure condition. In a new study published in Scientific Reports, researchers found that people who ...

Veterans Affairs department officials said Monday they have launched a study to determine how removing race from widely used lung function tests may affect disability benefits for veterans, and they ...

A landmark Northwestern Medicine study published in JAMA suggests lung transplantation can significantly extend survival in ...